S. Zeki

发表

Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis

J. Dunn, R. Rusu, M. Fox, 2021, Gut.

Endoscopic management of dysplasia and early oesophageal cancer.

J. Bergman, J. Dunn, S. Zeki, 2018, Best practice & research. Clinical gastroenterology.

Stem cells and their implications for colorectal cancer

T. Graham, N. Wright, S. Zeki, 2011, Nature Reviews Gastroenterology &Hepatology.

Regular feedback to individual endoscopists is associated with improved adenoma detection rate and other key performance indicators for colonoscopy

S. Zeki, G. Tritto, Samuel Lim, 2022, Frontline Gastroenterology.

TNE: moving from endoscopy to the clinical outpatient–blue sky thinking in oesophageal testing

J. Dunn, S. Zeki, T. Wong, 2022, Frontline Gastroenterology.

The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands

H. Barr, R. Poulsom, S. Kadirkamanathan, 2014, Gut.

Squamous cell carcinoma after radiofrequency ablation for Barrett's dysplasia.

R. Haidry, L. Lovat, N. Wright, 2014, World journal of gastroenterology.

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus

V. Goh, D. Landau, J. Lagergren, 2019, BJS open.

Low-cost and clinically applicable copy number profiling using repeat DNA

R. Fitzgerald, A. Noorani, A. Lynch, 2018, bioRxiv.

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI

S. Withey, V. Goh, N. Griffin, 2021, European Journal of Hybrid Imaging.

Does a high Mandard score really de ﬁ ne a poor response to chemotherapy in oesophageal adenocarcinoma?

S. Ngan, S. Zeki, J. Meenan, 2021 .

Targeting care in Barrett's oesophagus.

R. Fitzgerald, S. Zeki, 2014, Clinical medicine.

Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens.

D. Cunningham, W. Allum, S Kumar, 2022, European journal of cancer.

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre

M. Lomer, M. Samaan, P. Pavlidis, 2022, Alimentary pharmacology & therapeutics.

Clonal Selection and Persistence in Dysplastic Barrett's Esophagus and Intramucosal Cancers After Failed Radiofrequency Ablation

R. Haidry, L. Lovat, T. Graham, 2013, The American Journal of Gastroenterology.

Genomics of Esophageal Cancer and Biomarkers for Early Detection.

R. Fitzgerald, S. Zeki, Mark Pusung, 2016, Advances in experimental medicine and biology.

The use of molecular markers in predicting dysplasia and guiding treatment.

R. Fitzgerald, S. Zeki, 2015, Best practice & research. Clinical gastroenterology.

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

Rebecca C Fitzgerald, Carlos Caldas, Arusha Oloumi, 2014, Nature Genetics.

Crypt dysplasia in Barrett's oesophagus shows clonal identity between crypt and surface cells

T. Graham, N. Wright, R. Odze, 2013, The Journal of pathology.

Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?

J. Gossage, A. Davies, H. Deere, 2021, British Journal of Cancer.

Transition from esophagectomy to endoscopic therapy for early esophageal cancer.

J. Lagergren, J. Zylstra, J. Gossage, 2021, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?

M. Samaan, S. Anderson, P. Irving, 2022, Frontline Gastroenterology.

Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings

P. Irving, S. Zeki, K. Gecse, 2022, Frontline Gastroenterology.

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

V. Goh, N. Griffin, J. Lagergren, 2022, Annals of Surgical Oncology.

A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.

R. Fitzgerald, J. Bergman, S. Meijer, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

N. Griffin, J. Lagergren, J. Gossage, 2023, European Radiology.

Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.

S. Withey, V. Goh, A. Davies, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

54 Evaluation of a Minimally-Invasive Cytosponge Esophageal Cell Collection System in Patients With Barrett's Esophagus

S. Sami, R. Haidry, L. Lovat, 2015 .

Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)

R. Edwards, S. O’Toole, J. Steier, 2023, BMJ open.

Reply to Westerveld et al. and Schembri et al.

J. O'donohue, J. Dunn, S. Zeki, 2017, Endoscopy.

Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.

A. Davies, J. Lagergren, J. Gossage, 2023, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery

J. Lagergren, J. Gossage, A. Davies, 2021, Supportive Care in Cancer.

PWE-131 Endoscopically treatable t1 oesophageal adenocarcinoma diagnosed by emr – what is the value of ct, pet and eus?

R. Rusu, S. Zeki, J. Meenan, 2017, Gut.

Six-Food Elimination Diet Is Less Effective During Pollen Season in Adults With Eosinophilic Esophagitis Sensitized to Pollens

E. Savarino, S. Till, S. Zeki, 2023, The American journal of gastroenterology.

Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease

E. Savarino, C. Gyawali, M. Bellini, 2022, American Journal of Gastroenterology.

Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care Use.

E. Savarino, B. Barberio, S. Zeki, 2023, The journal of allergy and clinical immunology. In practice.

Extended Wireless pH Monitoring Significantly Increases Gastroesophageal Reflux Disease Diagnoses in Patients With a Normal pH Impedance Study

J. Gossage, G. Sui, A. Botha, 2023, Journal of neurogastroenterology and motility.

938 IMPEDANCE-PH FINDINGS CONFIRM THAT GRADE B ESOPHAGITIS PROVIDES OBJECTIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE

E. Savarino, C. Gyawali, M. Bellini, 2023, Gastroenterology.

The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands

H. Barr, R. Poulsom, S. Kadirkamanathan, 2014, Gut.